Covered recipient · General Payments record
COLLEEN MARIE KRISS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,876.31
- Reported across 139 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.31 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $206.93 | 19 |
| ABBVIE INC. | $89.64 | 4 |
| Abbott Laboratories | $40.24 | 2 |
| Astellas Pharma US Inc | $24.72 | 1 |
| PFIZER INC. | $19.37 | 1 |
| Amgen Inc. | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.12 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125325904 | CMS |
| Abbott Laboratories | $20.12 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125325906 | CMS |
| ABBVIE INC. | $27.09 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104111042 | CMS |
| ABBVIE INC. | $21.72 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104111044 | CMS |
| ABBVIE INC. | $19.81 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104111046 | CMS |
| ABBVIE INC. | $21.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104111048 | CMS |
| Amgen Inc. | $14.41 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117302019 | CMS |
| Astellas Pharma US Inc | $24.72 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139297626 | CMS |
| Novo Nordisk Inc | $10.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097165227 | CMS |
| Novo Nordisk Inc | $12.63 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937723 | CMS |
| Novo Nordisk Inc | $11.37 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097750794 | CMS |
| Novo Nordisk Inc | $10.01 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590445 | CMS |
| Novo Nordisk Inc | $10.38 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097107403 | CMS |
| Novo Nordisk Inc | $10.82 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097806267 | CMS |
| Novo Nordisk Inc | $10.56 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610388 | CMS |
| Novo Nordisk Inc | $12.68 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097332669 | CMS |
| Novo Nordisk Inc | $8.71 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097350629 | CMS |
| Novo Nordisk Inc | $8.94 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096928258 | CMS |
| Novo Nordisk Inc | $11.63 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097185769 | CMS |
| Novo Nordisk Inc | $10.77 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096903261 | CMS |
| Novo Nordisk Inc | $10.51 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097716386 | CMS |
| Novo Nordisk Inc | $10.63 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096686078 | CMS |
| Novo Nordisk Inc | $11.51 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097748359 | CMS |
| Novo Nordisk Inc | $11.24 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097682958 | CMS |
| Novo Nordisk Inc | $11.59 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097145206 | CMS |
| Novo Nordisk Inc | $11.16 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096705418 | CMS |
| Novo Nordisk Inc | $10.83 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097421604 | CMS |
| PFIZER INC. | $19.37 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131222257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.